Demonstration of a protein immunochemically related to glial fibrillary acidic protein in human fibroblasts in culture  by Bock, Elisabeth et al.
Volume 83, number 2 FEBS LETTERS November 1977 
DEMONSTRATION OF A PROTEIN IMMUNOCHEMICALLY RELATED TO GLIAL 
FIBRILLARY ACIDIC PROTEIN IN HUMAN FIBROBLASTS IN CULTURE 
Elisabeth BOCK*, S$ren RASMUSSEN*, Morten M@LLER* and Peter EBBESEN+ 
*The Protein Laboratory, University of Copenhagen, 34 Sigurdsgade, DK-2200 Copenhagen N, *Anatomy Dept. B, 
University of Copenhagen, I, Universitetsparken, DK-2100 Copenhagen @ and +Institu te of Medical Microbiology, 
Tumorvirology Dept., 22, Juliane Mariesvej, DK-2100 Copenhagen (8, Denmark 
Received 13 September 1977 
1, Introduction 
The glial filament, 8-10 nm in diameter, is mor- 
phologically similar to the neurofilament and the 
intermediate filament found in a variety of cells and 
tissues [l-7] . A soluble protein has been isolated 
from gliotic areas from brain [8]. Antisera prepared 
against this protein give apparently specific glial 
staining by indirect immunofluorescence methods 
[9], and the protein has therefore been termed the 
glial fibrillary acidic protein (GFA). It has been 
proposed that this protein was the subunit of the glial 
filament. Recent comparative studies of GFA and 
neurofilament proteins [lo] , and the isolation of a 
GFA-like protein from peripheral nerves, where glial 
fibres are not present [ 1 I] indicated similarity of 
the protein subunit of glial and nerve filaments. This 
finding strongly suggests the possibility that cyto- 
filament in other non-neural cells might also be com- 
posed of similar protein subunits. The characteristics 
of the neurofilament protein and GFA differ very 
much from those of actin and of tubulin and, there- 
fore, encourages the consideration of intermediate 
filaments as a separate class of organelles on a bio- 
chemical as well as a morphological basis. In this 
study we report the demonstration of a protein 
immunochemically related to GFA present in human 
fibroblasts. 
2. Materials and methods 
2.1. Purification of GFA 
GFA was purified from normal human brain 
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obtained at autopsy approximately 8 h post mortem 
using hydroxylapatite chromatography as described 
by Dahl and Bignami [ 121 . The purified protein was 
tested by means of sodium dodecylsulphate polyacryl. 
amide gel electrophoresis, using a gradient gel (PAA 
4/30, Pharmacia Fine Chemicals). The GFA prepara- 
tion consisted of 4 polypeptides in the range from 
55 000.-.40 000 daltops. 
2.2. Fibroblast cultures 
Whole skin biopsies were obtained from healthy 
adults. One mm pieces were seeded in plastic flasks 
in Modified Eagles Medium with 10% fetal calf serum 
and kept at 37”C, 5% COz. After 6 weeks the bottom 
was covered with fibroblasts whereas other cell types 
had died off. Secondary and tertiary cultures were 
established after loosening of the cells with trypsin. 
For extraction of antigens secondary and tertiary 
cultures derived from three different individuals were 
used. The nutrient medium was removed and the 
cultures washed twice in 10 ml phosphate buffered 
saline (PBS, pH 7.4,37’C), and loosened by a rubber 
policeman. The antigens were extracted with 0.05 M 
sodium phosphate buffer, pH 8.0 after a first extrac- 
tion of the cell suspension with 0.01 M sodium phos- 
phate/0.01 M MgC12 buffer, pH 6.2 (extract A). The 
suspension was centrifuged at 40 000 X g for 30 min. 
The supernatant was studied by crossed immuno- 
electrophoresis and used for absorption of anti-GFA 
activity. In some experiments the cell suspension was 
extracted by the phosphate buffer, pH 8.0, directly 
and used for crossed immunoelectrophoresis (extract 
B). 
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2.3. Antiserum against GFA 
Human brain GFA isolated from multiple sclerosis 
plaques was kindly supplied by Dr L. F. Eng, USA, 
and antiserum was raised in rabbits. The antiserum 
reacted with only one antigen when tested against 
extracts of human brain. This antigen was identified 
as GFA using purified GFA [ 131. The specificity of 
the antiserum was shown to be identical to a GFA 
antiserum kindly supplied by Drs Dahl and Bignami, 
USA [13]. 
2.4. Immunohistochemical staining 
Secondary and tertiary cultures were washed in PBS 
and fixed at 4°C for 30 min in 1% formaldehyde, 
freshly prepared from paraformaldehyde. They were 
thereafter sequentially incubated in 30 min steps in 
the following reagents: (1) anti-GFA rabbit antiserum 
(diluted 1: 1.50 or 1:300); (2) peroxidase labelled swine 
anti-rabbit IgG (diluted 1:20). The dilutions were 
performed in phosphate buffered saline. Each step 
was followed by washing in phosphate-buffered saline 
for 3 X 5 min. By a S-l.5 min reaction with a mixture 
containing 0.05% 3,3’-diaminobenzidinetetrahydro- 
chloride and 0.005% hydrogen peroxyde in 0.05 M 
Tris-HCl buffer (pH 7.6), the peroxidase bound to the 
cells formed the brown insoluble reaction product. 
Control of the specificity of the staining was per- 
formed by omitting either anti-GFA rabbit antiserum 
or peroxidase labelled swine anti-rabbit IgG. Further- 
more the specific anti-GFA was replaced by pre- 
immune rabbit serum or anti-GFA antiserum absorbed 
with purified GFA. In order to avoid soluble antigen- 
antibody complexes in the absorbed antiserum the 
optimal ratio between GFA and anti-GFA was 
determined by Sewell titration [ 141 . 
Fig.1. Immunohistochemical demonstration of GFA-positive filaments (arrows) in cultured fibroblasts. The indirect peroxidase- 
labelled immunoglobulin technique has been used for the demonstration. The bar represents 10 pm. 
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2.5. Immunodiffusion test 
Extracts of fibroblasts were analysed by Ouchter- 
lony’s double diffusion test [ 151 in agarose gel for 
24-48 h. 
2 6. Crossed immunoelectrophoresis 
This was performed as described by Weeke [ 161 . 
The antigens were separated by agarose gel electro- 
phoresis (1st dimension electrophoresis). After having 
turned the electric field 90” the electrophoresis was 
continued into an antibody containing gel (2nd 
dimension electrophoresis). The antigen-antibody 
complexes precipitate in arches delimiting an area 
proportional to the amount of antigen and inversely 
proportional to the concentration of antibodies. GFA 
antiserum absorbed with fibroblast culture extract 
was tested by means of crossed immunoelectropho- 
resis with intermediate gel [ 171 . This is a modified 
crossed immunoelectrophoresis in which an inter- 
mediate gel containing the antiserum under investiga- 
tion is placed between the 1st and the 2nd dimension 
gel. During the 2nd dimension electrophoresis GFA 
migrate through the intermediate gel and thereafter 
through the 2nd dimension gel. Depending upon the 
titre of the absorbed antiserum in the intermediate 
gel GFA will be completely, partially or not retarded 
by immunoprecipitation in the intermediate gel, 
indicating no absorption, partial absorption or com- 
plete absorption of the antiserum. 
3. Results 
By phase-contrast microscopy the cultivated fibro- 
blasts were seen as bipolar cells with long extending 
processes. Using GFA antiserum all the cells in the 
cultures were stained by the immunohistochemical 
procedure, fig.1. The peroxidase reaction product was 
confined to a cytoplasmatic filamentous network. No 
staining of the nucleus was seen. When the fibroblasts 
were treated with preimmune control sera, no staining 
was observed, fig.2. Furthermore, the specific staining 
of the cells was completely abolished when antiserum 
absorbed with the purified human brain GFA protein 
was used in the immunohistochemical reaction. How- 
ever, extracts of fibroblast cultures (extracts A and B) 
Fig.2. Control picture from cultured fibroblasts. Rabbit serum has been used in the immunohistochemical reaction instead of the 
specific GFA antiserum. The bar represents 10 Mm. 
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Fig.3. Crossed immunoelectrophoresis with intermediate gel of 0.33 pg purified human GFA. The reference antiserum in the 
upper gel was anti GFA (0.533 pi/cm’). The intermediate gel in fig.3A contained 200 ~1 consisting of 2 ~1 anti-GFA and 198 ~1 
20 mM Tris-barbital buffer pH 8.6. The intermediate gel in fig.3B contained 200 ~1 consisting of 2 ~1 antiCFA and 198 ~1 
fibroblast extract A corresponding to 102 pg protein. A pronounced decrease of anti GFA titre was seen after absorption with 
fibroblast extract. For explanation see Materials and methods. 
were unable to form immunoprecipitate either by 
Ouchterlony’s double diffusion test or crossed 
immunoelectrophoresis. When GFA antiserum was 
absorbed with fibroblast (extract A) a decrease in 
GFA antiserum titre was demonstrated by means of 
crossed immunoelectrophoresis with intermediate 
gel, see fig.3. This indicated that although the fibro- 
blast extract did not contain an antigen which was 
able to form insoluble antigen/antibody precipitates 
with GFA antiserum, the fibroblast extract contained 
an antigen which was able to absorb some GFA- 
antibody activity. The general effect of the fibroblast 
extract on rabbit immunoglobulins was tested by 
addition of fibroblast extract A to a rabbit antiserum 
against human transferrin. No changes in antibody 
titre could be demonstrated in this control experiment. 
4. Discussion 
The results indicate that an antigen immunochemi- 
tally partially identical to brain GFA is present in 
human fibroblasts, as demonstrated by an immuno- 
histochemical procedure. The fibroblast antigen was 
able to bind GFA antibodies leading to a decreased 
titre of the GFA antiserum as demonstrated by 
crossed immunoelectrophoresis with intermediate gel. 
However, the antigen-antibody complexes seemed to 
be soluble as no immunoprecipitate was obtained by 
means of double diffusion technique or ordinary 
crossed immunoelectrophoresis. A possible explana- 
tion is that the xtracted fibroblast antigen only 
share one or a few antigenic determinants with human 
brain GFA, as revealed by the present antiserum. 
Whether the fibroblast antigen is a part of the 8-10 
nm filaments present in this cell type has to be veri- 
fied by demonstration of specific binding of the anti- 
serum at the ultrastructural level. 
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